Christian joined Lundbeckfonden in 2012 and is the managing partner of Lundbeckfonden BioCapital, the evergreen biotech investment unit of Lundbeckfonden and part of the leadership team of Lundbeckfonden. Christian applies more than 20 years of experience across drug development, biotech and venture capital. He is the chairperson of the board of directors of SNIPR Biome and Cytoki Pharma and member of the board of directors of IO Biotech, NMD Pharma, Afyx Therapeutics. He was a co-founder, VP and CEO of 7TM Pharma. Christian holds a PhD in Pharmacology from the University of Copenhagen, Denmark.
Christian Elling, Ph.D.
Member – Lundbeckfonden